TransMedics Group

TransMedics Group

Health Care Equipment & Supplies
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

$3.3B

Market Cap • 11/19/2026

2018

(8 years)

Founded

2019

(7 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

5,9

P/S

4,5

P/EBITDA

25,7

P/OCF

29,1

P/FCF

73,1

P/E

25,5

BVPS

15,9

EPS

3,6

Market Cap

Market Cap

3,3B

EV

3,6B

EV/Revenue

5

EV/EBITDA

28,7

EV/EBIT

42,1

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-0,3%

Total Yield

-0,3%

Payout

0%

Retained Earnings

-238,9M

Profitability

Gross Margin

58,6%

EBITDA Margin

17,4%

EBIT Margin

11,9%

Net Margin

19,9%

D&A/EBITDA

0%

R&D/Revenue

14,6%

Capex/Revenue

9,3%

Capex/D&A

167,4%

Capex/OCF

60,2%

SBC/OCF

36,1%

% PPE

46,9%

% Goodwill

1,2%

ROE

31,9%

ROIC

12,9%

Growth

CAGR Revenue 5Y

91,5%

Leverage

N.D./EBITDA

2,9

Debt/Equity

0%

Current Ratio

4,5

Quick Ratio

4

Interest Coverage

345,5%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium